Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: Multiplex quantification with path analysis

Brain, Behavior, and Immunity

Volumn 25, Issue 8, 2011, Pages 1637-1648

  Erickson, Michelle A ^a,c   Banks, William A ^a,b,c  

^a Veterans Affairs Puget Sound Health Care System   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain; Chemokines; Cytokines; LPS; Multiplex; Path analysis; Serum

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD LEVEL; BRAIN LEVEL; CELLULAR IMMUNITY; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; CHEMOKINES; CYTOKINES; LIPOPOLYSACCHARIDES; MICE; NERVE TISSUE PROTEINS; RADIOPHARMACEUTICALS; SERUM ALBUMIN, RADIO-IODINATED; SIGNAL TRANSDUCTION;

EID: 80053900477     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.06.006     Document Type: Article

References (58)

1. Abazyan B., Nomura J., Kannan G., Ishizuka K., Tamashiro K.L., Nucifora F., et al. Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol. Psychiatry 2010, 68:1172-1181.
2. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37:13-25.
3. Banks W.A. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr. Pharm. Des. 2005, 11:973-984.
4. Banks W.A. The blood-brain barrier as a cause of obesity. Curr. Pharm. Des. 2008, 14:1606-1614.
5. Banks W.A., Erickson M.A. The blood-brain barrier and immune function and dysfunction. Neurobiol. Dis. 2010, 37:26-32.
6. Banks, W.A., Robinson, S.M., 2009. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav. Immun.
7. Banks W.A., Robinson S.M. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav. Immun. 2010, 24:102-109.
8. Banks W.A., Ortiz L., Plotkin S.R., Kastin A.J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 1991, 259:988-996.
9. Banks W.A., Kastin A.J., Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 1994, 179:53-56.
10. Banks W.A., Kastin A.J., Brennan J.M., Vallance K.L. Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide. Exp. Neurol. 1999, 156:165-171.
11. Banks W.A., Ercal N., Price T.O. The blood-brain barrier in neuroAIDS. Curr. HIV Res. 2006, 4:259-266.
12. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986, 51:1173-1182.
13. Baykal A., Kaynaroglu V., Hascelik G., Sayek I., Sanac Y. Epinephrine and endotoxin tolerance differentially modulate serum cytokine levels to high-dose lipopolysaccharide challenge in a murine model. Surgery 1999, 125:403-410.
14. Blatteis C.M. Role of the OVLT in the febrile response to circulating pyrogens. Prog. Brain Res. 1992, 91:409-412.
15. Brown C.M., Mulcahey T.A., Filipek N.C., Wise P.M. Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta. Endocrinology 2010, 151:4916-4925.
16. Castaneda T.R., Tong J., Datta R., Culler M., Tschop M.H. Ghrelin in the regulation of body weight and metabolism. Front. Neuroendocrinol. 2010, 31:44-60.
17. Cavaillon J.M., Adrie C., Fitting C., Adib-Conquy M. Endotoxin tolerance. Is there a clinical relevance?. J. Endotoxin Res. 2003, 9:101-107.
18. Chakravarty S., Herkenham M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 2005, 25:1788-1796.
19. Chen R., Zhou H., Beltran J., Malellari L., Chang S.L. Differential expression of cytokines in the brain and serum during endotoxin tolerance. J. Neuroimmunol. 2005, 163:53-72.
20. Combrinck M.I., Perry V.H., Cunningham C. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 2002, 112:7-11.
21. Conti B., Tabarean I., Andrei C., Bartfai T. Cytokines and fever. Front. Biosci. 2004, 9:1433-1449.
22. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol. 2009, 66:300-305.
23. Datta S.C., Opp M.R. Lipopolysaccharide-induced increases in cytokines in discrete mouse brain regions are detectable using Luminex xMAP technology. J. Neurosci. Methods 2008, 175:119-124.
24. del Rey A., Randolf A., Wildmann J., Besedovsky H.O., Jessop D.S. Re-exposure to endotoxin induces differential cytokine gene expression in the rat hypothalamus and spleen. Brain Behav. Immun. 2009, 23:776-783.
25. Erroi A., Fantuzzi G., Mengozzi M., Sironi M., Orencole S.F., Clark B.D., et al. Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infect Immun. 1993, 61:4356-4359.
26. Fox C., Dingman A., Derugin N., Wendland M.F., Manabat C., Ji S., et al. Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 2005, 25:1138-1149.
27. Goehler L.E., Gaykema R.P., Nguyen K.T., Lee J.E., Tilders F.J., Maier S.F., et al. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?. J. Neurosci. 1999, 19:2799-2806.
28. Gutierrez E.G., Banks W.A., Kastin A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 1993, 47:169-176.
29. Horani M.H., Mooradian A.D. Effect of diabetes on the blood brain barrier. Curr. Pharm. Des. 2003, 9:833-840.
30. Jaeger L.B., Dohgu S., Sultana R., Lynch J.L., Owen J.B., Erickson M.A., et al. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav. Immun. 2009, 23:507-517.
31. Jin L., Li J., Nation R.L., Nicolazzo J.A. Impact of p-glycoprotein inhibition and lipopolysaccharide administration on blood-brain barrier transport of colistin in mice. Antimicrob. Agents Chemother. 2011, 55:502-507.
32. Kelley K.W., Bluthe R.M., Dantzer R., Zhou J.H., Shen W.H., Johnson R.W., et al. Cytokine-induced sickness behavior. Brain Behav. Immun. 2003, 17(Suppl. 1):S112-S118.
33. Komaki G., Arimura A., Koves K. Effect of intravenous injection of IL-1 beta on PGE2 levels in several brain areas as determined by microdialysis. Am. J. Physiol. 1992, 262:E246-E251.
34. Lynch J.L., Banks W.A. Opiate modulation of IL-1alpha, IL-2, and TNF-alpha transport across the blood-brain barrier. Brain Behav. Immun. 2008, 22:1096-1102.
35. Marcondes M.C., Burdo T.H., Sopper S., Huitron-Resendiz S., Lanigan C., Watry D., et al. Enrichment and persistence of virus-specific CTL in the brain of simian immunodeficiency virus-infected monkeys is associated with a unique cytokine environment. J. Immunol. 2007, 178:5812-5819.
36. Moro M.A., Hurtado O., Cardenas A., Romera C., Madrigal J.L., Fernandez-Tome P., et al. Expression and function of tumour necrosis factor-alpha-converting enzyme in the central nervous system. Neurosignals 2003, 12:53-58.
37. Mrak R.E., Griffin W.S. Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol. Aging 2001, 22:903-908.
38. Nonaka N., Hileman S.M., Shioda S., Vo T.Q., Banks W.A. Effects of lipopolysaccharide on leptin transport across the blood-brain barrier. Brain Res. 2004, 1016:58-65.
39. Nonaka N., Shioda S., Banks W.A. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier. Exp. Neurol. 2005, 191:137-144.
40. O'Connor J.C., McCusker R.H., Strle K., Johnson R.W., Dantzer R., Kelley K.W. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell Immunol. 2008, 252:91-110.
41. Opal S.M., DePalo V.A. Anti-inflammatory cytokines. Chest 2000, 117:1162-1172.
42. Osburg B., Peiser C., Domling D., Schomburg L., Ko Y.T., Voigt K., et al. Effect of endotoxin on expression of TNF receptors and transport of TNF-alpha at the blood-brain barrier of the rat. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E899-E908.
43. Pan W., Banks W.A., Kastin A.J. Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury. Exp. Neurol. 1997, 146:367-373.
44. Pan W., Yu C., Hsuchou H., Zhang Y., Kastin A.J. Neuroinflammation facilitates LIF entry into brain: role of TNF. Am. J. Physiol. Cell Physiol. 2008, 294:C1436-C1442.
45. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
46. Reale M., Greig N.H., Kamal M.A. Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases. Mini Rev. Med. Chem. 2009, 9:1229-1241.
47. Roth J., De Souza G.E. Fever induction pathways: evidence from responses to systemic or local cytokine formation. Braz. J. Med. Biol. Res. 2001, 34:301-314.
48. Stamou P., Kontoyiannis D.L. Posttranscriptional regulation of TNF mRNA: a paradigm of signal-dependent mRNA utilization and its relevance to pathology. Curr. Dir. Autoimmun. 2010, 11:61-79.
49. Stefani M., Liguri G. Cholesterol in Alzheimer's disease: unresolved questions. Curr. Alzheimer Res. 2009, 6:15-29.
50. Steiner A.A., Chakravarty S., Rudaya A.Y., Herkenham M., Romanovsky A.A. Bacterial lipopolysaccharide fever is initiated via Toll-like receptor 4 on hematopoietic cells. Blood 2006, 107:4000-4002.
51. Tonelli L.H., Postolache T.T. Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge. Neurol. Res. 2005, 27:679-684.
52. Verma S., Nakaoke R., Dohgu S., Banks W.A. Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide. Brain Behav. Immun. 2006, 20:449-455.
53. Weberpals M., Hermes M., Hermann S., Kummer M.P., Terwel D., Semmler A., et al. NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits. J. Neurosci. 2009, 29:14177-14184.
54. Wuchert F., Ott D., Murgott J., Rafalzik S., Hitzel N., Roth J., et al. Rat area postrema microglial cells act as sensors for the toll-like receptor-4 agonist lipopolysaccharide. J. Neuroimmunol. 2008, 204:66-74.
55. Xaio H., Banks W.A., Niehoff M.L., Morley J.E. Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res. 2001, 896:36-42.
56. Zetterstrom M., Sundgren-Andersson A.K., Ostlund P., Bartfai T. Delineation of the proinflammatory cytokine cascade in fever induction. Ann. N.Y. Acad. Sci. 1998, 856:48-52.
57. Zhao L.R., Navalitloha Y., Singhal S., Mehta J., Piao C.S., Guo W.P., et al. Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Exp. Neurol. 2007, 204:569-573.
58. Zlokovic B.V., Deane R., Sagare A.P., Bell R.D., Winkler E.A. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid beta-peptide elimination from the brain. J. Neurochem. 2010, 115:1077-1089.